Z17.0 – Estrogen receptor positive status [ER+]

ICD-10-CM 2027 diagnosis code · Estrogen, and other hormones and factors receptor status (Z17)

Billable code

ICD-10-CM code Z17.0
Code
Z17.0 (claims format: Z170)
Description
Estrogen receptor positive status [ER+]
Billable
Yes – valid for HIPAA-covered transactions
Valid for
Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter
21. Factors influencing health status and contact with health services (Z00-Z99)
Block
Z17 Estrogen, and other hormones and factors receptor status (Z17)
Parent codes
Z17

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

Z17 – Estrogen, and other hormones and factors receptor status

Code first:
  • malignant neoplasm, such as:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of ovary (C56.-)
Notes:

Index terms for Z17.0

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in Z17

Frequently asked questions

What is ICD-10 code Z17.0?

Z17.0 is the ICD-10-CM code for estrogen receptor positive status [ER+], in the block Z17 (Estrogen, and other hormones and factors receptor status (Z17)).

Is Z17.0 a billable code?

Yes. Z17.0 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does Z17.0 belong to?

It belongs to category Z17 – Estrogen, and other hormones and factors receptor status.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.